A small North Carolina-based biotech got a lot smaller Tuesday, despite the company announcing its rare disease drug met the primary goal of a pivotal Phase 3 stu...

The Medicines Company on Saturday released data from a long-term safety study of its experimental cholesterol-lowering drug inclisiran in heart disease patients, ...

Array's Mektovi and Braftovi, when combined with Erbitux, produced a survival benefit in patients with BRAF-positive colon cancer. (Array BioPharma) The news tha...

More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, accord...

An experimental immunology drug from Eli Lilly has scored positive data in a mid-stage study of Crohn's disease patients.The study enrolled 180 participants, who rec...

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following managemen...

Bristol-Myers Squibb said a late-stage Opdivo study showed the medicine failed to prolong overall survival in patients with a type of newly diagnosed brain cancer.Th...

An experimental drug from Myovant Sciences met its main goal in a Phase 3 trial of women with uterine fibroids, results which keep the biotech on track to file the d...

The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer) Pfize...